Your browser doesn't support javascript.
loading
ABSTRACT
Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.
Texte intégral: 1 Indice: WPRIM Type d'étude: Guideline langue: En Texte intégral: Journal of Neurogastroenterology and Motility Année: 2022 Type: Article
Texte intégral: 1 Indice: WPRIM Type d'étude: Guideline langue: En Texte intégral: Journal of Neurogastroenterology and Motility Année: 2022 Type: Article